Skip to content

FP7H2020HORIZON

Orion OYJ

Country
FIFinland
Defence projects
0
Projects, all programmes
20
As coordinator
0
EU contribution (CORDIS)
EUR 141,750
Active
2008 to 2025

Projects

20 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
HAIFHuman-Centric Artificial Intelligence for Sustainable FutureHORIZON2025Associated partnerEUR 0
ETERNITYFuEl ThE bRaiN In healtThY aging and agE-relateD diseasesHORIZON2023Associated partnerEUR 0
TransPharmTransforming into a sustainable European pharmaceutical sectorHORIZON2022ParticipantEUR 0
PIONEERProstate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRopeH20202018ParticipantEUR 0
EQIPDEuropean Quality In Preclinical DataH20202017ParticipantEUR 0
TransQSTTranslational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030H20202017ParticipantEUR 0
TreatERClinical study in Parkinson's disease with two unique goals: 1) Proof-of-concept of CDNF protein for disease modification; 2) Validation of clinically tested device for intracerebral drug deliveryH20202017ParticipantEUR 48,750
PHAGOInflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976H20202016ParticipantEUR 0
CANCER-IDCancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in bloodFP72015ParticipantNot stated
CHEM21Chemical Manufacturing Methods for the 21st Century Pharmaceutical IndustriesFP72012ParticipantNot stated
STEMBANCCStem cells for Biological Assays of Novel drugs and prediCtive toxiCology (StemBANCC)FP72012ParticipantNot stated
ORBITOOral biopharmaceutics toolsFP72012ParticipantNot stated
MIP-DILIMechanism-Based Integrated Systems for the Prediction of Drug-Induced Liver InjuryFP72012ParticipantNot stated
PREDECTNew Models for Preclinical Evaluation of Drug Efficacy in Common Solid TumoursFP72011ParticipantNot stated
SAFESCIMETEuropean Modular Education and Training Programme in Safety Sciences for MedicinesFP72010ParticipantNot stated
EMTRAINEuropean Medicines Research Training NetworkFP72009ParticipantNot stated
NEWMEDSNovel Methods leading to New Medications in Depression and SchizophreniaFP72009ParticipantNot stated
EU2PEuropean programme in Pharmacovigilance and PharmacoepidemiologyFP72009ParticipantNot stated
PHARMATRAINPharmaceutical Medicine Training ProgrammeFP72009ParticipantNot stated
PROSPERProstate cancer: profiling and evaluation of ncRNAFP72008ParticipantEUR 93,000

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.